BioLine RX Ltd

BLRX06 Dec 2024
Healthcare
$0.27
-0.06 (-5.96%)
Lowest Today
$0.25
Highest Today
$0.28
Today’s Open
$0.27
Prev. Close
$0.27
52 Week High
$1.89
52 Week Low
$0.25
To Invest in BioLine RX Ltd

BioLine RX Ltd

Healthcare
BLRX06 Dec 2024
-0.06 (-5.96%)
1M
3M
6M
1Y
5Y
Low
$0.25
Day’s Range
High
$0.28
0.25
52 Week Low
$0.25
52-Week Range
52 Week High
$1.89
0.25
1 Day
-
1 Week
-12.74%
1 month return
-42.36%
3 month return
-58.48%
6 month return
-63.09%
1 Year return
-84.4%
3 Years return
-87.97%
5 Years return
-88.71%
10 Years return
-
Institutional Holdings
Alyeska Investment Group, L.P.
1.03
CVI Holdings LLC
0.97
Envestnet Asset Management Inc
0.28
Morgan Stanley - Brokerage Accounts
0.23
Values First Advisors Inc
0.23
Atria Investments LLC
0.16
Atria Wealth Solutions, Inc.
0.11

Market Status

Fundamentals
Market Cap
27.49 mln
PB Ratio
2.77
PE Ratio
0
Enterprise Value
27.93 mln
Total Assets
63.92 mln
Volume

Company Financials

Fund house & investment objective

Company Information
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Organisation
BioLine RX Ltd
Employees
79
Industry
Biotechnology
CEO
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step